Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|Inflammatory Breast Cancer|Male Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: tamoxifen citrate|DRUG: busulfan|DRUG: thiotepa|DRUG: melphalan|BIOLOGICAL: aldesleukin|BIOLOGICAL: sargramostim|PROCEDURE: peripheral blood stem cell transplantation|RADIATION: radiation therapy
Sponsor: Fred Hutchinson Cancer Center
Collaborators: National Cancer Institute (NCI)